Corruption in Science News ArticlesExcerpts of key news articles on corruption in science
If you follow the news about health research, you risk whiplash. First garlic lowers bad cholesterol, then—after more study—it doesn’t. Hormone replacement reduces the risk of heart disease in postmenopausal women, until a huge study finds that it doesn’t. But what if wrong answers aren’t the exception but the rule? More and more scholars who scrutinize health research are now making that claim. It isn’t just an individual study here and there that’s flawed, they charge. Instead, the very framework of medical investigation may be off-kilter, leading time and again to findings that are at best unproved and at worst dangerously wrong. The result is a system that leads patients and physicians astray—spurring often costly regimens that won’t help and may even harm you. Even a cursory glance at medical journals shows that once heralded studies keep falling by the wayside. A major study concluded there’s no good evidence that statins (drugs like Lipitor and Crestor) help people with no history of heart disease. The study ... was based on an evaluation of 14 individual trials with 34,272 patients. Cost of statins: more than $20 billion per year. “Positive” drug trials, which find that a treatment is effective, and “negative” trials, in which a drug fails, take the same amount of time to conduct. But negative trials took an extra two to four years to be published. With billions of dollars on the line, companies are loath to declare a new drug ineffective. As a result of the lag in publishing negative studies, patients receive a treatment that is actually ineffective. From clinical trials of new drugs to cutting-edge genetics, biomedical research is riddled with incorrect findings.
Note: For the good of your health, the entire article at the link above is well worth reading. For lots more on how the profit-oriented health profession puts public health at risk, click here and here.
They're some of the most trusted voices in the defense of vaccine safety: the American Academy of Pediatrics, Every Child By Two, and pediatrician Dr. Paul Offit. But CBS News has found these three have something more in common - strong financial ties to the industry whose products they promote and defend. The vaccine industry gives millions to the Academy of Pediatrics for conferences, grants, medical education classes and even helped build their headquarters. The totals are kept secret, but public documents reveal bits and pieces. A $342,000 payment from Wyeth, maker of the pneumococcal vaccine - which makes $2 billion a year in sales. A $433,000 contribution from Merck, the same year the academy endorsed Merck's HPV vaccine - which made $1.5 billion a year in sales. Every Child By Two, a group that promotes early immunization for all children, admits the group takes money from the vaccine industry, too - but wouldn't tell us how much. Then there's Paul Offit, perhaps the most widely-quoted defender of vaccine safety. He's gone so far as to say babies can tolerate "10,000 vaccines at once." In fact, he's a vaccine industry insider. Offit holds a $1.5 million dollar research chair at Children's Hospital, funded by Merck. He holds the patent on an anti-diarrhea vaccine he developed with Merck. And future royalties for the vaccine were just sold for $182 million cash.
Note: An excellent report endorsed by many respected doctors and nurses reveals the serious risks of vaccines. Read an incisive list of questions regarding vaccines that are rarely raised by the media. The report accessible on this US government webpage states, "Since 1988, over 24,200 petitions have been filed with the VICP [Vaccine Injury Compensation Program] ... with 8,162 of those determined to be compensable. Total compensation paid over the life of the program is approximately $4.5 billion." Why isn't that huge price tag for vaccine injuries being talked about?
Over the past three years, more than 60 institutions, including several of the world's most prestigious research centers, have been criticized by the U.S. government for failing to protect human subjects adequately. As recently as 1974 individual scientists and their financial backers could decide for themselves what constituted ethical research. Most of the time their judgment was sound, but there were plenty of appalling exceptions. In the 1950s Army doctors gave LSD to soldiers without telling them what it was. In 1963 researchers injected prisoners and terminally ill patients with live cancer cells to test their immune responses; they were told only that it was a "skin test." In the 1950s mentally retarded children at Willowbrook, a state institution in New York, were deliberately infected with hepatitis so that scientists could work on an experimental vaccine. And in perhaps the most infamous case on record, doctors at Georgia's Tuskegee Institute, starting in the 1930s, deliberately withheld treatment from syphilis-infected African-American men for 40 years to monitor the course of the disease. Financial conflicts of interest can extend not only to the institutions but also to the researchers themselves. Jesse Gelsinger's death in the University of Pennsylvania's gene-therapy trial in 1999 seemed especially scandalous [because] James Wilson, the principal investigator in the study, held a 30% equity stake in Genovo, which owned the rights to license the drug Wilson was studying; the university owned 3.2% of the company. When Targeted Genetics Corp. acquired Genovo, Wilson reportedly earned $13.5 million and Penn $1.4 million.
Note: For a powerful, reliable list of astounding incidents in which government and medical professionals used humans as guinea pigs over the past hundred years and continuing to the present, click here. Links are provided to reliable sources for verification. For key facts on government mind control programs, click here.
A leading medical journal is launching a global campaign to separate medicine from big pharma. The BMJ [British Medical Journal] says doctors are being unduly influenced by industry-sponsored education events and industry-funded trials for major drugs. Those trials cannot be trusted, the journal's editor and a team of global healthcare leaders write in a scathing editorial. The "endemic financial entanglement with industry is distorting the production and use of healthcare evidence, causing harm to individuals and waste for health systems", they write. They are calling for governments to start funding independent trials of new drugs and medical devices, rather than relying on industry-funded studies. Sponsored research is more likely to find a favourable result compared to independent research. And they want medical associations to discourage doctors from going to industry-funded education events. Assistant Professor Ray Moynihan [is a] researcher studying the link between money and medicine and is one of the leaders of The BMJ's campaign. “When we want to decide on a medicine or a surgery, a lot of the evidence we used to inform that decision is biased," he says. "It cannot be trusted. Because so much of that has been produced and funded by the manufacturers of those healthcare products." Dr Moynihan points to ... Johnson & Johnson, which sold pelvic mesh to thousands of Australian women. It knew the mesh could cause serious harm, but never properly warned women of the risks.
Note: Read the highly revealing comments of Marcia Angell, former editor-in-chief of the New England Journal of Medicine, on the massive corruption she found in the medical industry. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
The Coalition for Mercury-free Drugs (CoMeD) exposes communications between Centers for Disease Control (CDC) personnel and vaccine researchers revealing U.S. officials apparently colluded in covering-up the decline in Denmark's autism rates following the removal of mercury from vaccines. Documents obtained via the Freedom of Information Act (FOIA) show that CDC officials were aware of Danish data indicating a connection between removing Thimerosal (49.55% mercury) and a decline in autism rates. Despite this knowledge, these officials allowed a 2003 article to be published in Pediatrics that excluded this information, misrepresented the decline as an increase, and led to the mistaken conclusion that Thimerosal in vaccines does not cause autism. In Denmark, Thimerosal, a controversial mercury compound used as a preservative in certain vaccines, was removed from all Danish vaccines in 1992. The well-publicized Danish study published in Pediatrics 2003 claimed that autism rates actually increased after Thimerosal was phased out. This study subsequently became a cornerstone for the notion that mercury does not cause autism. However, one of the FOIA documents obtained from CDC clearly indicates that this study omitted large amounts of data showing autism rates actually dropping after mercury was removed from Danish vaccines.
Note: For the complete text of the article, which has been taken down from the Sacramento Bee website, click here. Read about a key scientific study which showed that monkeys given standard human vaccines developed autism symptoms, at this link. And an MSNBC/Associated Press report shows that the FDA rejected limits on thimerosal and that "most doses of flu vaccine still contain thimerosal."
Dr. Fiona Godlee, editor of the BMJ [British Medical Journal], specializes in the unexpected. [A marionette puppet on her desk is] dressed as a doctor, complete with a stethoscope around its neck. Its strings represent the hidden hand of the pharmaceutical industry. Godlee keeps it ... to remind her of the dark forces at work in science and medicine. And she is blunt about the results: "I think we have to call it what it is. It is the corruption of the scientific process." Hundreds of papers are being pulled from the scientific record, for falsified data, for plagiarism, and for a variety of other reasons that are often never explained. Sometimes it's an honest mistake. But it's estimated that 70 per cent of the retractions are based on some form of scientific misconduct. As the editor of one of the oldest and most influential medical journals, Godlee is leading several campaigns to change the way science is reported, including opening up data for other scientists to review, and digging up data from old and abandoned trials for a second look. She has strong words about the overuse of drugs, and the influence of industry on the types of questions that scientists ask, and the conclusions that are drawn from the evidence. "I do have a belief in the fundamentality of science to correct itself. We can't do that under the blanket of secrecy," she says. It matters, Godlee says, because bad science can be dangerous. "We do know that patients are harmed, and we know that the health systems are harmed as a result of poor science."
Note: Retraction Watch is fascinating reading for anyone interested in what goes on behind science's closed doors. Read also the revealing comments of Marcia Angell, former editor-in-chief of the New England Journal of Medicine, on the massive corruption she found in the health industry. For more along these lines, see concise summaries of deeply revealing science corruption news articles from reliable major media sources.
Peer review is supposed to be the pride of the rigorous academic publishing process. But increasingly journals are finding out that those supposedly authoritative checks are being rigged. In the latest episode of the fake peer review phenomenon, one of the world’s largest academic publishers, Springer, has retracted 64 articles from 10 of its journals after discovering that their reviews were linked to fake e-mail addresses. The announcement comes nine months after 43 studies were retracted by BioMed Central (one of Springer’s imprints) for the same reason. Retraction Watch co-founder Ivan Oransky ... said he didn’t know of any instances of retractions for faked peer reviews before 2012. In a report for the journal Nature last fall, Oransky and his colleagues told the story of a ... researcher who wrote peer reviews for 28 of his own papers. Investigations ... have also uncovered a number of services selling names and contact information for made-up experts guaranteed to give an expedited, positive review. In a statement on its Web site in February, the Committee on Publication Ethics (COPE) detailed these agencies’ “systematic, inappropriate attempts” to manipulate the process. COPE’s chair Ginny Barbour wrote in December, “The uncovering of companies systematically manipulating publications, by the use of fake reviewers and more, offers an alarming glimpse into what can happen if reward systems are implemented with no thought or oversight.”
Note: The editor of a top medical journal recently suggested that half all of scientific literature may simply be untrue. For more along these lines, see concise summaries of deeply revealing news articles about corruption in science.
Shocking as it may seem, U.S. government doctors once thought it was fine to experiment on disabled people and prison inmates. Such experiments included giving hepatitis to mental patients in Connecticut, squirting a pandemic flu virus up the noses of prisoners in Maryland, and injecting cancer cells into chronically ill people at a New York hospital. Much of this horrific history is 40 to 80 years old, but it is the backdrop for a meeting in Washington this week by a presidential bioethics commission. The meeting was triggered by the government's apology last fall for federal doctors infecting prisoners and mental patients in Guatemala with syphilis 65 years ago. U.S. officials also acknowledged there had been dozens of similar experiments in the United States. Inevitably, they will be compared to the well-known Tuskegee syphilis study. In that episode, U.S. health officials tracked 600 black men in Alabama who already had syphilis but didn't give them adequate treatment even after penicillin became available. Though people in the studies were usually described as volunteers, historians and ethicists have questioned how well these people understood what was to be done to them and why, or whether they were coerced. In the last 15 years, two international studies sparked outrage. U.S.-funded doctors failed to give the AIDS drug AZT to all the HIV-infected pregnant women in a study in Uganda even though it would have protected their newborns. The other study, by Pfizer Inc., gave an antibiotic named Trovan to children with meningitis in Nigeria, although there were doubts about its effectiveness. Critics blamed the experiment for the deaths of 11 children and the disabling of scores of others. Pfizer settled a lawsuit with Nigerian officials for $75 million but admitted no wrongdoing.
Note: Though it appears these highly unethical studies have stopped in the US, the article points out that many drug companies are now doing their studies in countries where ethical codes are not strong. For an astounding list of government-sponsored programs where humans were used as guinea pigs, click here. For a two-page summary of solid evidence of government involvement in mind control programs, click here.
In Minnesota, pigs are being born with human blood in their veins. In Nevada, there are sheep whose livers and hearts are largely human. In California, mice peer from their cages with human brain cells firing inside their skulls. Biologists call these hybrid animals chimeras, after the mythical Greek creature with a lion's head, a goat's body and a serpent's tail. Chimeras are allowing scientists to watch, for the first time, how nascent human cells and organs mature and interact ... inside the bodies of living creatures. But with no federal guidelines in place ... how human must a chimera be before more stringent research rules should kick in? Chimerism becomes a more sensitive topic when it involves growing entire human organs inside animals. And it becomes especially sensitive when it deals in brain cells. Imagine, said Robert Streiffer, a professor of philosophy and bioethics at the University of Wisconsin, a human-chimpanzee chimera endowed with speech ... what some have called a "humanzee." Perhaps the most ambitious efforts to make use of chimeras come from Irving Weissman, director of Stanford University's Institute of Cancer/Stem Cell Biology and Medicine. Weissman helped make the first mouse with a nearly complete human immune system. More recently his team injected human neural stem cells into mouse fetuses, creating mice whose brains are about 1 percent human. Now Weissman says he is thinking about making chimeric mice whose brains are 100 percent human.
Note: If the above link fails, click here.
The remains of what has been described as a huge lost city may force historians and archaeologists to radically reconsider their view of ancient human history. Marine scientists say archaeological remains discovered 36 metres (120 feet) underwater in the Gulf of Cambay off the western coast of India could be over 9,000 years old. The vast city - which is five miles long and two miles wide - is believed to predate the oldest known remains in the subcontinent by more than 5,000 years. Debris recovered from the site - including construction material, pottery, sections of walls, beads, sculpture and human bones and teeth has been carbon dated and found to be nearly 9,500 years old. The city is believed to be even older than the ancient Harappan civilisation, which dates back around 4,000 years. Author and film-maker Graham Hancock - who has written extensively on the uncovering of ancient civilisations [said,] "Cities on this scale are not known in the archaeological record until roughly 4,500 years ago when the first big cities begin to appear in Mesopotamia. Nothing else on the scale of the underwater cities of Cambay is known. There's a huge chronological problem in this discovery. It means that the whole model of the origins of civilisation with which archaeologists have been working will have to be remade from scratch," he said.
Note: Dozens of manmade complexes found under the ocean have been found, yet mainstream archeologists are largely ignoring these finds because they don't fit the academic consensus. For an excellent compilation of reliable, mainstream media news articles showing both the hidden history and suppressed archeology of our world, click here. For an interview with former Economist reporter Graham Hancock, who finds lots of solid, astounding evidence of a lost civilization, click here.
Weren't we taught that radio was invented by an Italian named Guglielmo Marconi? And that the legendary Thomas Alva Edison devised today's electrical power system? "We were taught wrong," said Toby Grotz, president of the International Tesla Society. Two years before Marconi demonstrated his wireless radio transmission, [Nikola Tesla] performed an identical feat at the 1893 World's Fair in Chicago. On June 21, 1943, in the case of Marconi Wireless Telegraph Co. vs. the United States, the Supreme Court ruled that that Tesla's radio patents had predated those of the Italian genius. To be sure, Edison invented the incandesent light bulb. But he powered it and all of his other projects with inefficient direct current (DC) electricity. It was Tesla who discovered how to use the far more powerful phased form of alternating current (AC) electricity that is virtually the universal type of electricity employed by modern civilization. There are indications that Tesla also discovered many of the devices ... for the Pentagon's controversial Star Wars antimissile defense system. "Tesla dreamed of supplying limitless amounts of power freely and equally available to all persons on Earth," said Grotz. And he was convinced he could do so by broadcasting electrical power across large distances just as radio transmits far smaller amounts of energy. [Tesla's] tests ... caused lights to burn as much as 26 miles away, according to news reports of the time.
Note: Tesla was written out of history texts likely because he advocated providing methods for extremely cheap electricity available to everyone. He successfully transmitted electricity through the air to lights 26 miles away. Yet the rich energy power brokers of his time could not stand for this. Only the little known Supreme Court ruling mentioned above restored his claim as original inventor of the radio. For lots more on this most fascinating genius, click on the article link above and click here and here. For revealing major media articles showing the suppression of other energy inventions which could transform our world, click here.
[A] symposium – on the reproducibility and reliability of biomedical research, held at the Wellcome Trust in London last week – touched on one of the most sensitive issues in science today: the idea that something has gone fundamentally wrong. The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness. In their quest for telling a compelling story, scientists too often sculpt data to fit their preferred theory of the world. Journal editors deserve their fair share of criticism too. We aid and abet the worst behaviours. Journals are not the only miscreants. Universities are in a perpetual struggle for money and talent, endpoints that foster reductive metrics. National assessment procedures ... incentivise bad practices. And individual scientists, including their most senior leaders, do little to alter a research culture that occasionally veers close to misconduct. Part of the problem is that no-one is incentivised to be right. Instead, scientists are incentivised to be productive. The conclusion of the symposium was that something must be done. The good news is that science is beginning to take some of its worst failings very seriously. The bad news is that nobody is ready to take the first step to clean up the system.
Note: The Lancet is considered by many to be the most prestigious medical journal in the world. If the editor-in-chief of the Lancet is making these comments, who can we trust? Can we really "trust the science?" Read a powerfully revealing essay by former editor-in-chief of the New England Journal of Medicine Marcia Angell on how the drug companies blatantly manipulate science for profit.
Imagine a world where wireless devices are as small as a grain of salt. These miniaturized devices have sensors, cameras and communication mechanisms to transmit the data they collect back to a base in order to process. Today, you no longer have to imagine it: microelectromechanical systems (MEMS), often called motes, are real and they very well could be coming to a neighborhood near you. With such a small size, these devices can stay suspended in an environment just like a particle of dust. They can: Collect data including acceleration, stress, pressure, humidity, sound and more from sensors; Process the data with what amounts to an onboard computer system; Store the data in memory; Wirelessly communicate the data to the cloud, a base or other MEMs. Since smart dust devices are miniature sensors they can record anything that they are programmed to record. Since they are so small, they are difficult to detect. Your imagination can run wild regarding the negative privacy implications when smart dust falls into the wrong hands. Once billions of smart dust devices are deployed over an area it would be difficult to retrieve or capture them if necessary. The volume of smart dust that could be engaged by a rogue individual, company or government to do harm would make it challenging for the authorities to control. Many of the applications for smart dust are still in the concept stage. We might not know when it will progress to the point of wide-scale adoption, but ... it’s a question of when rather than if.
Note: This takes privacy issues to an entirely new level. This AP article states the supermicro chips are "just 0.002 inches by 0.002 inches and look like bits of powder. They're thin enough to be embedded in a piece of paper." They are also small enough to slip into a vaccine unnoticed. And check out another Forbes article titled "Stratospheric Balloons Will Rain Tiny Electronic Spies From The Sky." For more along these lines, see concise summaries of deeply revealing news articles on the disappearance of privacy from reliable major media sources.
It was a faustian bargain—and it certainly made editors at National Public Radio squirm. The deal was this: NPR, along with a select group of media outlets, would get a briefing about an upcoming announcement by the U.S. Food and Drug Administration a day before anyone else. But in exchange for the scoop, NPR would have to abandon its reportorial independence. The FDA would dictate whom NPR's reporter could and couldn't interview. “My editors are uncomfortable with the condition that we cannot seek reaction,” NPR reporter Rob Stein wrote back to the government officials offering the deal. Stein asked for a little bit of leeway to do some independent reporting but was turned down flat. Take the deal or leave it. NPR took the deal – along with reporters from more than a dozen other top-tier media organizations, including CBS, NBC, CNN, the Washington Post, the Wall Street Journal and the New York Times. This kind of deal offered by the FDA - known as a close-hold embargo - is an increasingly important tool used by scientific and government agencies to control the behavior of the science press. By using close-hold embargoes and other methods, the FDA, like other sources of scientific information, are gaining control of journalists who are supposed to keep an eye on those institutions. The watchdogs are being turned into lapdogs. It is hard to tell when a close-hold embargo is afoot because, by its very nature, it is a secret.
Note: And to see how the media is censored by big money and a corrupt judicial system, watch this incredible video of two crack reporters who had their major investigation into a public health threat shut down. For more along these lines, see concise summaries of deeply revealing news articles about corruption in science and the manipulation of public perception.
Recently, secret documents have been unearthed detailing what the energy industry knew about the links between their products and global warming. In the 1980s, oil companies like Exxon and Shell carried out internal assessments of the carbon dioxide released by fossil fuels, and forecast the planetary consequences of these emissions. In 1982, for example, Exxon predicted that by about 2060, CO2 levels would reach around 560 parts per million – double the preindustrial level – and that this would push the planet’s average temperatures up by about 2°C over then-current levels. in 1988, an internal report by Shell projected similar effects but also found that CO2 could double even earlier, by 2030. Privately, these companies did not dispute the links between their products, global warming, and ecological calamity. On the contrary, their research confirmed the connections. The effect is all the more chilling in view of the oil giants’ refusal to warn the public about the damage that their own researchers predicted. Although the details of global warming were foreign to most people in the 1980s, among the few who had a better idea than most were the companies contributing the most to it. Despite scientific uncertainties, the bottom line was this: oil firms recognized that their products added CO2 to the atmosphere, understood that this would lead to warming, and calculated the likely consequences. And then they chose to accept those risks on our behalf, at our expense, and without our knowledge.
When doctors are deciding which drug to prescribe a patient, the idea behind evidence-based medicine is that they inform their thinking by consulting scientific literature. To a great extent, this means relying on medical journals. The trouble is that pharmaceutical companies, who stand to win or lose large amounts of money depending on the content of journal articles, have taken a firm grip on what gets written about their drugs. That grip was strong way back in 2004, when The Lancet's chief editor Richard Horton lamented that "journals have devolved into information laundering operations for the pharmaceutical industry." It may be even tighter now. Drug companies exert this hold on knowledge through publication planning agencies, an obscure subsection of the pharmaceutical industry. The planning companies are paid to implement high-impact publication strategies for specific drugs. They target the most influential academics to act as authors, draft the articles, and ensure that these include clearly-defined branding messages and appear in the most prestigious journals. There are now at least 250 different companies engaged in the business of planning clinical publications for the pharmaceutical industry. Many firms are based in the UK and the east coast of the United States. Having talked to over a dozen publication planners I found that the standard approach to article preparation is for planners to work hand-in-glove with drug companies to create a first draft.
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
Hundreds of articles in medical journals claiming to be written by academics or doctors have been penned by ghostwriters in the pay of drug companies, an Observer inquiry reveals. The journals, bibles of the profession, have huge influence on which drugs doctors prescribe and the treatment hospitals provide. But The Observer has uncovered evidence that many articles written by so-called independent academics may have been penned by writers working for agencies which receive huge sums from drug companies to plug their products. Estimates suggest that almost half of all articles published in journals are by ghostwriters. While doctors who have put their names to the papers can be paid handsomely for 'lending' their reputations, the ghostwriters remain hidden. In the United States a legal case brought against drug firm Pfizer turned up internal company documents showing that it employed a New York medical writing agency. One document analyses articles about the anti-depressant Zoloft. Some of the articles lacked only one thing: a doctor's name. In the margin the agency had put the initials TBD, which Healy assumes means 'to be determined'. Dr Richard Smith, editor of the British Journal of Medicine, admitted ghostwriting was a 'very big problem'. 'We are being hoodwinked by the drug companies. The articles come in with doctors' names on them and we often find some of them have little or no idea about what they have written,' he said.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.
Last year, the National Institute for Allergy and Infectious Diseases, the organization led by Dr. Fauci, funded scientists at the Wuhan Institute of Virology and other institutions for work on gain-of-function research on bat coronaviruses. Many scientists have criticized gain of function research, which involves manipulating viruses in the lab to explore their potential for infecting humans, because it creates a risk of starting a pandemic from accidental release. The work entailed risks that worried even seasoned researchers. More than 200 scientists called for the work to be halted. Dr. Fauci played an important role in promoting the work. In 2019, with the backing of NIAID, the National Institutes of Health committed $3.7 million over six years for research that included some gain-of-function work. The program followed another $3.7 million, 5-year project for collecting and studying bat coronaviruses ... bringing the total to $7.4 million. [One] phase of the project [included] gain-of-function research for the purpose of understanding how bat coronaviruses could mutate to attack humans. According to Richard Ebright, an infectious disease expert at Rutgers University, the project ... would enhance the ability of bat coronavirus to infect human cells and laboratory animals using techniques of genetic engineering. SARS-CoV-2, the virus now causing a global pandemic, is believed to have originated in bats. U.S. intelligence, after originally asserting that the coronavirus had occurred naturally, conceded last month that the pandemic may have originated in a leak from the Wuhan lab.
Note: Newsweek reported that in 2017, Anthony Fauci predicted a "surprise outbreak" during Trump's presidency. How could he have known this? This Washington Post article has the title "State Department cables warned of safety issues at Wuhan lab studying bat coronaviruses." For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus pandemic from reliable major media sources.
In January 2018, the U.S. Embassy in Beijing took the unusual step of repeatedly sending U.S. science diplomats to the Wuhan Institute of Virology (WIV), which had in 2015 become China’s first laboratory to achieve the highest level of international bioresearch safety. WIV issued a news release in English about the last of these visits. Last week, WIV erased that statement from its website, though it remains archived on the Internet. What the U.S. officials learned during their visits concerned them so much that they dispatched two diplomatic cables ... back to Washington. The cables warned about safety and management weaknesses at the WIV lab and proposed more attention and help. The first cable ... warns that the lab’s work on bat coronaviruses and their potential human transmission represented a risk of a new SARS-like pandemic. “Most importantly,” the cable states, “this finding strongly suggests that SARS-like coronaviruses from bats can be transmitted to humans to cause SARS-like diseases." The Chinese government, meanwhile, has put a total lockdown on information related to the virus origins ... while suppressing any attempts to examine whether [their] lab was involved. The Shanghai lab that published the novel coronavirus genome on Jan. 11 was quickly shut down by authorities for “rectification.” Several of the doctors and journalists who reported on the spread early on have disappeared. The Chinese researchers at WIV were receiving assistance from the Galveston National Laboratory at the University of Texas Medical Branch and other U.S. organizations.
Note: The entire article at the link above raises vitally important questions, as does this Newsweek article titled, "Dr. Fauci Backed Controversial Wuhan Lab With Millions of U.S. Dollars for Risky Coronavirus Research." For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus pandemic from reliable major media sources.
In order to get prescription drugs approved by the Food and Drug Administration, companies must conduct clinical trials to show that the drugs are safe and effective. But drug companies don’t have direct access to human subjects, so they’ve always contracted with academic researchers to conduct the trials on patients in teaching hospitals and clinics. Traditionally, they gave grants to the institutions for interested researchers to test their drugs, then waited for the results and hoped that their products looked good. That began to change in the 1980s, partly as a result of a new law that permitted researchers and their institutions, even if funded by the National Institutes of Health ... to patent their discoveries and license them exclusively to drug companies in return for royalties. That made them business partners, and the sponsors became intimately involved in all aspects of the clinical trials. Drug company involvement biases research in ways that are not always obvious, often by suppressing negative results. A review of 74 clinical trials of antidepressants, for example, found that 37 of 38 positive studies — that is, studies that showed that a drug was effective — were published. But 33 of 36 negative studies were either not published or published in a form that conveyed a positive outcome. Bias can also be introduced through the design of a clinical trial. It’s often possible to make clinical trials come out the way you and your sponsors want. Disclosure is better than no disclosure, but it does not eliminate the conflict of interest.
Note: The above was written by Marcia Angell, former editor of The New England Journal of Medicine. For more, see this mercola.com article. Then see concise summaries of deeply revealing Big Parma corruption news articles from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.